The European Commission’s plan to introduce a transferable exclusivity voucher scheme in the EU to encourage the development of new antimicrobial drugs has run into trouble after a majority of the EU member states came out against the idea.
EU Countries Slam Transferable Exclusivity Voucher Proposal
A group of EU member states has written to the European Commission saying that an exclusivity voucher scheme intended to stimulate R&D into new antimicrobials will stifle innovation by competitor companies and push up costs for national health systems.
